Literature DB >> 7310576

Rubinstein-Taybi syndrome and nasopharyngeal rhabdomyosarcoma.

R A Sobel, S Woerner.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7310576     DOI： 10.1016/s0022-3476(81)80043-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.

Authors:  Adepitan A Owosho; Shih-Chiang Huang; Sonja Chen; Shruti Kashikar; Cherry L Estilo; Suzanne L Wolden; Leonard H Wexler; Joseph M Huryn; Cristina R Antonescu
Journal:  Oral Oncol       Date:  2016-09-06       Impact factor: 5.337

Review 2.  Rhabdomyosarcoma of the head and neck in children.

Authors:  Joanna Radzikowska; Wojciech Kukwa; Andrzej Kukwa; Anna Czarnecka; Antoni Krzeski
Journal:  Contemp Oncol (Pozn)       Date:  2015-02-13

3.  Benign and malignant tumors in Rubinstein-Taybi syndrome.

Authors:  Max V Boot; Martine J van Belzen; Lucy I Overbeek; Nathalie Hijmering; Matias Mendeville; Quinten Waisfisz; Pieter Wesseling; Raoul C Hennekam; Daphne de Jong
Journal:  Am J Med Genet A       Date:  2018-01-23       Impact factor: 2.802

4.  Nasal Embryonal Rhabdomyosarcoma in the Pediatric Population: Literature Review and Report of Midline Presentation.

Authors:  Jordan H Larson; Rachel Rutledge; Laura Hunnell; Daniel K Choi; Robert G Kellogg; Sanjay Naran
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-04-20

Review 5.  Pediatric Rhabdomyosarcoma: Epidemiology and Genetic Susceptibility.

Authors:  Bailey A Martin-Giacalone; P Adam Weinstein; Sharon E Plon; Philip J Lupo
Journal:  J Clin Med       Date:  2021-05-09       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.